{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:00:03Z","timestamp":1790740803084,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100204","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:38:44Z","timestamp":1787848724000},"page":"100204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interindividual variability in platelet aggregation among aspirin-treated patients: a large retrospective analysis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7801-4646","authenticated-orcid":false,"given":"Eleonora","family":"Schiera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1667-4548","authenticated-orcid":false,"given":"Simone","family":"De Corci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-8825","authenticated-orcid":false,"given":"Sergio","family":"Terracina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5941-9947","authenticated-orcid":false,"given":"Gioacchino","family":"Galardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1790-2574","authenticated-orcid":false,"given":"Gianluca","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-7299","authenticated-orcid":false,"given":"Massimo","family":"Mancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-396X","authenticated-orcid":false,"given":"Fabio M.","family":"Pulcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7329","key":"10.1016\/j.bvth.2026.100204_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bvth.2026.100204_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3324\/haematol.10999","article-title":"Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count","volume":"92","author":"Cattaneo","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bvth.2026.100204_bib3","article-title":"ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report","volume":"10","author":"Cesario","year":"2026","journal-title":"Eur Heart J Case Rep"},{"issue":"11","key":"10.1016\/j.bvth.2026.100204_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease","volume":"16","author":"Patrono","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"10283","key":"10.1016\/j.bvth.2026.100204_bib5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(21)00533-X","article-title":"Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"397","author":"Galli","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bvth.2026.100204_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.975969","article-title":"De-escalation of antiplatelet therapy in acute coronary syndromes: why, how and when?","volume":"9","author":"Galli","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.bvth.2026.100204_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.bvth.2026.100204_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacc.2014.05.049","article-title":"Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry","volume":"64","author":"Mayer","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100204_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-024-03022-w","article-title":"Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital","volume":"58","author":"Galli","year":"2025","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"10.1016\/j.bvth.2026.100204_bib10","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bvth.2026.100204_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.bvth.2026.100204_bib12","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bvth.2026.100204_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/09537104.2014.1003291","article-title":"Arachidonic acid-stimulated platelet tests: identification of patients less sensitive to aspirin treatment","volume":"26","author":"Temperilli","year":"2015","journal-title":"Platelets"},{"issue":"19","key":"10.1016\/j.bvth.2026.100204_bib14","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1161\/01.CIR.0000147228.29325.F9","article-title":"Platelet function testing in cardiovascular diseases","volume":"110","author":"Michelson","year":"2004","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.bvth.2026.100204_bib15","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo","year":"2022","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.bvth.2026.100204_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ehjcvp\/pvaf034","article-title":"Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy","volume":"11","author":"Galli","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"3","key":"10.1016\/j.bvth.2026.100204_bib17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11239-025-03204-0","article-title":"Enhanced GPVI-dependent platelet pro-adhesive activity in patients with advanced coronary artery disease","volume":"59","author":"Heydari","year":"2026","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.bvth.2026.100204_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2008.02.010","article-title":"Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome","volume":"156","author":"Bigalke","year":"2008","journal-title":"Am Heart J"},{"issue":"1-3","key":"10.1016\/j.bvth.2026.100204_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-5793(03)00337-5","article-title":"A PLC gamma 2-independent platelet collagen aggregation requiring functional association of GPVI and integrin alpha2beta1","volume":"542","author":"Mangin","year":"2003","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.bvth.2026.100204_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.STR.31.3.591","article-title":"Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin","volume":"31","author":"Kawasaki","year":"2000","journal-title":"Stroke"},{"issue":"42","key":"10.1016\/j.bvth.2026.100204_bib21","first-page":"2339","article-title":"The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis [in Hungarian]","volume":"140","author":"Tarjan","year":"1999","journal-title":"Orv Hetil"},{"issue":"8","key":"10.1016\/j.bvth.2026.100204_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9149(02)02718-2","article-title":"Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin","volume":"90","author":"Sane","year":"2002","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100204_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41569-026-01249-z","article-title":"Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies","volume":"23","author":"Galli","year":"2026","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100204_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/ejvs.2000.1294","article-title":"Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease","volume":"21","author":"Koksch","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"16","key":"10.1016\/j.bvth.2026.100204_bib25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/eurheartj\/ehaf473","article-title":"Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis","volume":"47","author":"Occhipinti","year":"2026","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.bvth.2026.100204_bib26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.bvth.2026.100204_bib27","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.106.635847","article-title":"The aspirin resistance controversy: clinical entity or platelet heterogeneity?","volume":"113","author":"Freedman","year":"2006","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.bvth.2026.100204_bib28","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/eurheartj\/ehaf552","article-title":"Dual antiplatelet therapy modulation strategies beyond standard of care: a promising path towards individualized antiplatelet treatment","volume":"47","author":"Sibbing","year":"2026","journal-title":"Eur Heart J"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:31:21Z","timestamp":1790739081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000690"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100204","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interindividual variability in platelet aggregation among aspirin-treated patients: a large retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100204"}}